Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression

Abstract Background N4-acetylcytidine (ac4C), a widespread modification in human mRNAs that is catalyzed by the N-acetyltransferase 10 (NAT10) enzyme, plays an important role in promoting mRNA stability and translation. However, the biological functions and regulatory mechanisms of NAT10-mediated ac...

Full description

Bibliographic Details
Main Authors: Min Deng, Long Zhang, Wenying Zheng, Jiale Chen, Nan Du, Meiqi Li, Weiqing Chen, Yonghong Huang, Ning Zeng, Yuanbin Song, Yongming Chen
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-022-02586-w
_version_ 1797836217229770752
author Min Deng
Long Zhang
Wenying Zheng
Jiale Chen
Nan Du
Meiqi Li
Weiqing Chen
Yonghong Huang
Ning Zeng
Yuanbin Song
Yongming Chen
author_facet Min Deng
Long Zhang
Wenying Zheng
Jiale Chen
Nan Du
Meiqi Li
Weiqing Chen
Yonghong Huang
Ning Zeng
Yuanbin Song
Yongming Chen
author_sort Min Deng
collection DOAJ
description Abstract Background N4-acetylcytidine (ac4C), a widespread modification in human mRNAs that is catalyzed by the N-acetyltransferase 10 (NAT10) enzyme, plays an important role in promoting mRNA stability and translation. However, the biological functions and regulatory mechanisms of NAT10-mediated ac4C were poorly defined. Methods ac4C mRNA modification status and NAT10 expression levels were analyzed in gastric cancer (GC) samples and compared with the corresponding normal tissues. The biological role of NAT10-mediated ac4C and its upstream and downstream regulatory mechanisms were determined in vitro and in vivo. The therapeutic potential of targeting NAT10 in GC was further explored. Results Here, we demonstrated that both ac4C mRNA modification and its acetyltransferase NAT10 were increased in GC, and increased NAT10 expression was associated with disease progression and poor patient prognosis. Functionally, we found that NAT10 promoted cellular G2/M phase progression, proliferation and tumorigenicity of GC in an ac4C-depedent manner. Mechanistic analyses demonstrated that NAT10 mediated ac4C acetylation of MDM2 transcript and subsequently stabilized MDM2 mRNA, leading to its upregulation and p53 downregulation and thereby facilitating gastric carcinogenesis. In addition, Helicobacter pylori (Hp) infection contributed to NAT10 induction, causing MDM2 overexpression and subsequent p53 degradation. Further investigations revealed that targeting NAT10 with Remodelin showed anti-cancer activity in GC and augmented the anti-tumor activity of MDM2 inhibitors in p53 wild-type GC. Conclusions These results suggest the critical role of NAT10-mediated ac4C modification in GC oncogenesis and reveal a previously unrecognized signaling cascade involving the Hp-NAT10-MDM2-p53 axis during GC development.
first_indexed 2024-04-09T15:05:10Z
format Article
id doaj.art-6a1f9ae9a4ce4f41a6fdf429a24e1789
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-04-09T15:05:10Z
publishDate 2023-01-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-6a1f9ae9a4ce4f41a6fdf429a24e17892023-04-30T11:31:51ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-01-0142111810.1186/s13046-022-02586-wHelicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progressionMin Deng0Long Zhang1Wenying Zheng2Jiale Chen3Nan Du4Meiqi Li5Weiqing Chen6Yonghong Huang7Ning Zeng8Yuanbin Song9Yongming Chen10Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineAffiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Key Laboratory of “Translational Medicine On Malignant Tumor Treatment”First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Technology Center of Digital MedicineSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineAbstract Background N4-acetylcytidine (ac4C), a widespread modification in human mRNAs that is catalyzed by the N-acetyltransferase 10 (NAT10) enzyme, plays an important role in promoting mRNA stability and translation. However, the biological functions and regulatory mechanisms of NAT10-mediated ac4C were poorly defined. Methods ac4C mRNA modification status and NAT10 expression levels were analyzed in gastric cancer (GC) samples and compared with the corresponding normal tissues. The biological role of NAT10-mediated ac4C and its upstream and downstream regulatory mechanisms were determined in vitro and in vivo. The therapeutic potential of targeting NAT10 in GC was further explored. Results Here, we demonstrated that both ac4C mRNA modification and its acetyltransferase NAT10 were increased in GC, and increased NAT10 expression was associated with disease progression and poor patient prognosis. Functionally, we found that NAT10 promoted cellular G2/M phase progression, proliferation and tumorigenicity of GC in an ac4C-depedent manner. Mechanistic analyses demonstrated that NAT10 mediated ac4C acetylation of MDM2 transcript and subsequently stabilized MDM2 mRNA, leading to its upregulation and p53 downregulation and thereby facilitating gastric carcinogenesis. In addition, Helicobacter pylori (Hp) infection contributed to NAT10 induction, causing MDM2 overexpression and subsequent p53 degradation. Further investigations revealed that targeting NAT10 with Remodelin showed anti-cancer activity in GC and augmented the anti-tumor activity of MDM2 inhibitors in p53 wild-type GC. Conclusions These results suggest the critical role of NAT10-mediated ac4C modification in GC oncogenesis and reveal a previously unrecognized signaling cascade involving the Hp-NAT10-MDM2-p53 axis during GC development.https://doi.org/10.1186/s13046-022-02586-wGastric cancerN4-acetylcytidineN-acetyltransferase 10MDM2p53Helicobacter pylori
spellingShingle Min Deng
Long Zhang
Wenying Zheng
Jiale Chen
Nan Du
Meiqi Li
Weiqing Chen
Yonghong Huang
Ning Zeng
Yuanbin Song
Yongming Chen
Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
Journal of Experimental & Clinical Cancer Research
Gastric cancer
N4-acetylcytidine
N-acetyltransferase 10
MDM2
p53
Helicobacter pylori
title Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
title_full Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
title_fullStr Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
title_full_unstemmed Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
title_short Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression
title_sort helicobacter pylori induced nat10 stabilizes mdm2 mrna via rna acetylation to facilitate gastric cancer progression
topic Gastric cancer
N4-acetylcytidine
N-acetyltransferase 10
MDM2
p53
Helicobacter pylori
url https://doi.org/10.1186/s13046-022-02586-w
work_keys_str_mv AT mindeng helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT longzhang helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT wenyingzheng helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT jialechen helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT nandu helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT meiqili helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT weiqingchen helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT yonghonghuang helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT ningzeng helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT yuanbinsong helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression
AT yongmingchen helicobacterpyloriinducednat10stabilizesmdm2mrnaviarnaacetylationtofacilitategastriccancerprogression